What other screening tools would you suggest for this case?
Questions:
1. Do you agree with the differential diagnoses of the patient? Why or why not
2. What other screening tools would you suggest for this case?
3. What other pharmacologic or non-pharmacologic intervention would you recommend for this patient?
References
Ahmed, S., Bachu, R., Kotapati, P., Adnan, M., Ahmed, R., Farooq, U., … & Begum, G. (2019). Use of gabapentin in the treatment of substance use and psychiatric disorders: a systematic review. Frontiers in psychiatry, 10, 228.
Park, S. C., & Kim, Y. K. (2020). Anxiety Disorders in the DSM-5: changes, controversies, and future directions. Anxiety Disorders, 187-196.
Rodrigues-Amorim, D., Olivares, J. M., Spuch, C., & Rivera-Baltanás, T. (2020). A systematic review of efficacy, safety, and tolerability of duloxetine. Frontiers in psychiatry, 11, 554899.
Yi, X. Y., Ni, S. F., Ghadami, M. R., Meng, H. Q., Chen, M. Y., Kuang, L., … & Zhou, X. Y. (2018). Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep medicine, 45, 25-32.
Ziffra, M. (2021). Panic disorder: A review of treatment options. Ann Clin Psychiatry, 33(2), 124-133.
Zimmerman, M., Martin, J., McGonigal, P., Harris, L., Kerr, S., Balling, C., … & Dalrymple, K. (2019). Validity of the DSM‐5 anxious distress specifier for major depressive disorder. Depression and anxiety, 36(1), 31-38.